Professor | Luo Ruoyu | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Luo Ruoyu

Contact Information

luory1018@126.com

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1980.09–1985.07 Bachelor of Clinical Medicine from Wuhan University 1988.09–1991.07 Master of Internal Medicine from Wuhan University 2000.03-2001.12 Studied Organ Transplant Molecular Biology at Stanford University, USA
Work Experience	2002.05-2009.02 Director of Gynecology and Obstetrics, Renmin Hospital, Wuhan University 2009.03-present Director of Gynecologic Department I, Deputy Director of Obstetrics and Gynecology, Renmin Hospital, Wuhan University
Awards	2004 Second Prize of Hubei Science and Technology Progress Award, Second Prize of Wuhan Science and Technology Progress Award 2006 Third Prize of Hubei Science and Technology Progress Award

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1980.09–1985.07 Bachelor of Clinical Medicine from Wuhan University
1988.09–1991.07 Master of Internal Medicine from Wuhan University
2000.03-2001.12 Studied Organ Transplant Molecular Biology at Stanford University, USA

Work Experience

2002.05-2009.02 Director of Gynecology and Obstetrics, Renmin Hospital, Wuhan University
2009.03-present Director of Gynecologic Department I, Deputy Director of Obstetrics and Gynecology, Renmin Hospital, Wuhan University

Awards

2004 Second Prize of Hubei Science and Technology Progress Award, Second Prize of Wuhan Science and Technology Progress Award
2006 Third Prize of Hubei Science and Technology Progress Award

Areas of Focus	Gynecologic Oncology Endometriosis
Publications	miR-187 inhibits the growth of cervical cancer cells by targeting FGF9, Hua Liang, RuoYu Luo, Xiaoqi Chen, Yuzi Zhao and Aili Tan, 2017 An increased risk of ovarian cancer associated with polymorphism in BRCC5 gene in Caucasian populations, Liang H, Li Y, Luo R Y, et al., 2014 MicroRNA-215 is a potential prognostic marker for cervical cancer, Liang H, Li Y, Luo R, et al., 2014

Areas of Focus

Gynecologic Oncology
Endometriosis

Publications

miR-187 inhibits the growth of cervical cancer cells by targeting FGF9, Hua Liang, RuoYu Luo, Xiaoqi Chen, Yuzi Zhao and Aili Tan, 2017
An increased risk of ovarian cancer associated with polymorphism in BRCC5 gene in Caucasian populations, Liang H, Li Y, Luo R Y, et al., 2014
MicroRNA-215 is a potential prognostic marker for cervical cancer, Liang H, Li Y, Luo R, et al., 2014

Cancer Surgery Gynecology Oncology Endometriosis Treatment Research Education Health Medical Hormones Therapy

Liwei Cao - Southern University of Science and Technology

Xin Xin Han - Southern University of Science and Technology

Jun Tian - Southern University of Science and Technology

View All

Personal Information